Literature DB >> 35121846

Osteomyelitis and antibiotic treatment in patients with grade IV pressure injury and spinal cord lesion-a retrospective cohort study.

Johanna Rigazzi1, Carina Fähndrich1,2, Rik Osinga3,4, Sandro Baumgartner1,5, Michael Baumberger1, Jörg Krebs1, Dirk Johannes Schaefer4, Markus Vogt5, Reto Wettstein4, Anke Scheel-Sailer6,7.   

Abstract

STUDY
DESIGN: Retrospective cohort study.
OBJECTIVES: To analyze characteristics and treatment of osteomyelitis (OM) in the treatment of grade IV pressure injury (PI) in patients with spinal cord injury/disorder (SCI/D) following the Basel Decubitus Concept.
SETTING: Acute care and rehabilitation clinic specialized in SCI/D.
METHODS: Patients with SCI/D were admitted for grade IV PI treatment between 1st January 2010 and 28th February 2015. Patients, SCI/D, and PI characteristics were collected from chart reviews. Descriptive statistics and differences between groups with and without OM were evaluated.
RESULTS: In total, 117 patients (87 male, 30 female) with 130 PI grade IV were included. In 95 patients (81%), OM was diagnosed histologically. In 87 cases, more than one bacterial species was involved. Out of 49 different bacterial species, Enterococcus faecalis and Staphylococus aureus were most frequently observed. Amoxicillin/clavulanic acid and ciprofloxacin were the most frequently used out of 24 different antibiotics. Length of antibiotic treatment varied between <8 days and >91 days with 31 patients receiving antibiotics for about 8 weeks. Complications occurred in all groups of antibiotic duration. Having a paraplegia, no OM and sacral PI was associated with increased complication rates, but the number of patients did not allow comprehensive risk factor analysis.
CONCLUSION: Because the variety of patients concerning SCI/D, PI, and OM characteristics did not show a conclusive relation between length of antibiotic treatment and complication rates, the development of a subgroup specific treatment concept for PI in patients with SCI/D would be favorable to further optimize antibiotic treatment.
© 2022. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35121846     DOI: 10.1038/s41393-022-00758-1

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.473


  2 in total

1.  Local flap therapy for the treatment of pressure sore wounds.

Authors:  Reto Wettstein; Mathias Tremp; Michael Baumberger; Dirk J Schaefer; Daniel F Kalbermatten
Journal:  Int Wound J       Date:  2013-10-17       Impact factor: 3.315

Review 2.  Bacteriology of pressure ulcers in individuals with spinal cord injury: What we know and what we should know.

Authors:  Ali N Dana; William A Bauman
Journal:  J Spinal Cord Med       Date:  2014-08-17       Impact factor: 1.985

  2 in total
  1 in total

1.  Hip Joint Infections Caused by Multidrug-Resistant Enterobacterales Among Patients With Spinal Cord Injury: Experience of a Reference Center in the Greater Paris Area.

Authors:  B Davido; L Noussair; F El Sayed; K Jaffal; H Le Liepvre; D Marmouset; T Bauer; J L Herrmann; M Rottman; A C Cremieux; A Saleh-Mghir
Journal:  Open Forum Infect Dis       Date:  2022-04-17       Impact factor: 4.423

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.